| 1244 |
Retinal degeneration II |
2 |
Drug
|
77.9 |
| 1245 |
Retinal degeneration I |
1 |
Human disease
|
9.0 |
| 1247 |
Spinal dysmyelination |
1 |
Target evidence
|
59.7 |
| 1248 |
Mucolipidosis II |
1 |
Human disease
|
24.0 |
| 1256 |
Woolly hair |
2 |
Human disease
|
6.5 |
| 1258 |
Obesity |
7 |
Target evidence
|
41.8 |
| 1260 |
Retinal atrophy - Rod-cone dysplasia 2, RD3-related |
1 |
Human disease
|
9.0 |
| 1261 |
Gluten-sensitive enteropathy |
1 |
Human disease
|
9.0 |
| 1264 |
Hydromelia |
1 |
Human disease
|
9.0 |
| 1266 |
Otitis media, predisposition to |
8 |
Human disease
|
15.0 |
| 1268 |
Pheochromocytoma |
2 |
Human disease
|
37.0 |
| 1269 |
Hyperaldosteronism |
1 |
Human disease
|
9.0 |
| 1270 |
Convulsions and ataxia, CACNA1A-related |
1 |
Drug
|
73.5 |
| 1271 |
Dwarfism, ACAN-related |
3 |
Target evidence
|
61.3 |
| 1272 |
Comedo syndrome |
1 |
Human disease
|
9.0 |
| 1278 |
Hypotrichosis, dominant |
2 |
Human disease
|
32.0 |
| 1283 |
Xanthinuria, generic |
5 |
Human disease
|
15.0 |
| 1286 |
Evans syndrome |
1 |
Human disease
|
21.5 |
| 1287 |
Keratitis |
3 |
Human disease
|
15.0 |
| 1289 |
Urticaria pigmentosa |
1 |
Human disease
|
29.0 |
| 1290 |
Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome |
1 |
Human disease
|
9.0 |
| 1292 |
Polyneuropathy, generic |
2 |
Human disease
|
12.0 |
| 1294 |
Dwarfism, growth-hormone-receptor deficiency |
1 |
Human disease
|
34.0 |
| 1298 |
Progressive rod-cone degeneration, PRCD-related |
1 |
Human gene
|
29.0 |
| 1299 |
Avian sarcoma and leukosis virus, subgroup A, susceptibility/resistance to |
1 |
Human disease
|
9.0 |
| 1302 |
Avian sarcoma and leukosis virus, subgroup B, susceptibility/resistance to |
1 |
Human disease
|
34.0 |
| 1309 |
Mucopolysaccharidosis IIIA |
1 |
Target evidence
|
84.4 |
| 1311 |
Photoreceptor dysplasia, PPT1-related |
1 |
Target evidence
|
58.4 |
| 1314 |
Retinal atrophy - Rod-cone dysplasia 3, PDE6A-related |
1 |
Drug
|
61.3 |
| 1315 |
Osteochondrodysplasia |
2 |
Human disease
|
12.0 |
| 1317 |
Mucopolysaccharidosis II |
2 |
Human disease
|
37.0 |
| 1318 |
Elliptocytosis, SPTB-related |
1 |
Human gene
|
34.0 |
| 1323 |
Dwarfism, GHR-related |
3 |
Human disease
|
34.0 |
| 1325 |
Protein-losing enteropathy |
1 |
Human disease
|
6.5 |
| 1326 |
Protein-losing nephropathy |
1 |
Human disease
|
9.0 |
| 1331 |
Eclampsia |
1 |
Human disease
|
9.0 |
| 1334 |
Sperm, short tail |
3 |
Human gene
|
35.0 |
| 1335 |
Renal cystadenocarcinoma and nodular dermatofibrosis, FLCN-related |
1 |
Target evidence
|
57.1 |
| 1339 |
Von Willebrand disease II |
2 |
Drug
|
63.4 |
| 1340 |
Complex vertebral malformation |
3 |
Target evidence
|
62.1 |
| 1341 |
Night blindness, congenital stationary, TRPM1-related |
1 |
Human disease
|
14.0 |
| 1342 |
Mucopolysaccharidosis IIIB |
4 |
Target evidence
|
65.4 |
| 1345 |
Tricuspid valve dysplasia |
2 |
Human disease
|
12.0 |
| 1346 |
Retinal atrophy, progressive, autosomal dominant, RHO-related |
3 |
Target evidence
|
50.7 |
| 1348 |
Atrichia with papular lesions |
1 |
Target evidence
|
54.9 |
| 1353 |
Scott syndrome |
1 |
Target evidence
|
59.0 |
| 1360 |
Trimethylaminuria (fishy taint) |
4 |
Human gene
|
40.0 |
| 1361 |
Dysplasia epiphysealis hememelica |
1 |
Human disease
|
9.0 |
| 1365 |
Achromatopsia-3, CNGB3-related |
2 |
Target evidence
|
62.6 |
| 1366 |
Retinal dysplasia and degeneration |
1 |
Target evidence
|
53.4 |